HIV-1 Escape from the CCR5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of gp120-CCR5 Engagement That Attenuates Macrophage Tropism
Michael Roche(The University of Melbourne), Paul R. Gorry(RMIT University), Sharon R. Lewin(Peter Doherty Institute), Martin R. Jakobsen(Aarhus University), Benhur Lee(Icahn School of Medicine at Mount Sinai), Filippo Posta(University of California, Los Angeles), Jasminka Sterjovski(Monash University), Mike Westby(Pfizer (United States)), Melissa J. Churchill(Monash University), Becky Jubb(Pfizer (United States)), Anne Ellett(Monash University), Paul A. Ramsland(Burnet Institute)
Cited by 82
Related Papers
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k
Non-canonical Activation of the DNA Sensing Adaptor STING by ATM and IFI16 Mediates NF-κB Signaling after Nuclear DNA Damage
|Molecular Cell|2018|663
Immune checkpoint blockade in infectious diseases
|Nature reviews. Immunology|2017|571